The NIH Somatic Cell Genome Editing program,Nature

当前位置： X-MOL 学术 › Nature › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The NIH Somatic Cell Genome Editing program
Nature ( IF 64.8 ) Pub Date : 2021-04-07 , DOI: 10.1038/s41586-021-03191-1
Krishanu Saha _{1,

2,

3,

4} , Erik J Sontheimer ₅ , P J Brooks ₆ , Melinda R Dwinell ₇ , Charles A Gersbach ₈ , David R Liu _{9,

10,

11} , Stephen A Murray ₁₂ , Shengdar Q Tsai ₁₃ , Ross C Wilson ₁₄ , Daniel G Anderson _{15,

16,

17} , Aravind Asokan _{8,

18} , Jillian F Banfield _{14,

19} , Krystof S Bankiewicz ₂₀ , Gang Bao ₂₁ , Jeff W M Bulte _{22,

23} , Nenad Bursac ₈ , Jarryd M Campbell ₂₄ , Daniel F Carlson ₂₄ , Elliot L Chaikof ₂₅ , Zheng-Yi Chen _{26,

27,

28} , R Holland Cheng ₂₉ , Karl J Clark ₃₀ , David T Curiel ₃₁ , James E Dahlman ₃₂ , Benjamin E Deverman ₃₃ , Mary E Dickinson ₃₄ , Jennifer A Doudna _{14,

35,

36,

37,

38,

39,

40} , Stephen C Ekker ₃₀ , Marina E Emborg _{41,

42} , Guoping Feng ₄₃ , Benjamin S Freedman _{44,

45,

46,

47} , David M Gamm _{4,

48} , Guangping Gao ₄₉ , Ionita C Ghiran ₅₀ , Peter M Glazer ₅₁ , Shaoqin Gong _{1,

3,

4} , Jason D Heaney ₅₂ , Jon D Hennebold ₅₃ , John T Hinson ₅₄ , Anastasia Khvorova ₅ , Samira Kiani ₅₅ , William R Lagor ₃₄ , Kit S Lam ₅₆ , Kam W Leong ₅₇ , Jon E Levine ₄₂ , Jennifer A Lewis ₅₈ , Cathleen M Lutz ₁₂ , Danith H Ly ₅₉ , Samantha Maragh ₆₀ , Paul B McCray ₆₁ , Todd C McDevitt _{62,

63} , Oleg Mirochnitchenko ₆₄ , Ryuji Morizane ₆₅ , Niren Murthy _{14,

66} , Randall S Prather ₆₇ , John A Ronald ₆₈ , Subhojit Roy ₆₉ , Sushmita Roy _{1,

3,

4,

70} , Venkata Sabbisetti ₇₁ , W Mark Saltzman ₇₂ , Philip J Santangelo ₃₂ , David J Segal ₅₆ , Mary Shimoyama ₇₃ , Melissa C Skala _{1,

4,

74} , Alice F Tarantal _{75,

76,

77,

78} , John C Tilton ₇₉ , George A Truskey ₈ , Moriel Vandsburger ₆₆ , Jonathan K Watts ₅ , Kevin D Wells ₆₇ , Scot A Wolfe ₈₀ , Qiaobing Xu ₈₁ , Wen Xue ₅ , Guohua Yi ₈₂ , Jiangbing Zhou ₈₃ ,

Affiliation

Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Department of Medical History & Bioethics, University of Wisconsin-Madison, Madison, WI, USA.
Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, WI, USA.
McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA.
RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.
Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Bethesda, MD, USA.
Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA.
Department of Biomedical Engineering, Duke University, Durham, NC, USA.
Merkin Institute of Transformative Technologies, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
Howard Hughes Medical Institute, Cambridge, MA, USA.
The Jackson Laboratory, Bar Harbor, ME, USA.
Department of Hematology, St Jude Children's Research Hospital, Memphis, TN, USA.
Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA, USA.
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology, Cambridge, MA, USA.
Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
Department of Earth and Planetary Sciences, University of California, Berkeley, Berkeley, CA, USA.
Department of Neurological Surgery, Ohio State University, Columbus, OH, USA.
Department of Bioengineering, Rice University, Houston, TX, USA.
Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Recombinetics, Inc, Eagan, MN, USA.
Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA, USA.
Program in Neuroscience, Harvard Medical School, Boston, MA, USA.
Eaton-Peabody Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
Department of Molecular and Cellular Biology, University of California, Davis, Davis, CA, USA.
Department of Biochemistry and Molecular Biology, Mayo Clinic Rochester, Rochester, MN, USA.
Department of Radiation Oncology, Washington University in St Louis, St Louis, MO, USA.
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA.
Department of Chemistry, University of California, Berkeley, Berkeley, CA, USA.
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.
California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, Berkeley, CA, USA.
Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA, USA.
Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Gladstone Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA, USA.
Department of Medical Physics, University of Wisconsin-Madison, Madison, WI, USA.
Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, USA.
McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Division of Nephrology, University of Washington, Seattle, WA, USA.
Kidney Research Institute, University of Washington, Seattle, WA, USA.
Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
Department of Medicine, University of Washington, Seattle, WA, USA.
Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, USA.
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Department of Therapeutic Radiology, Yale University, New Haven, CT, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, USA.
Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT, USA.
Pittsburgh Liver Research Center, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, USA.
Department of Biomedical Engineering, Columbia University, New York, NY, USA.
Wyss Institute, Harvard University, Cambridge, MA, USA.
Department of Chemistry, Carnegie-Mellon University, Pittsburgh, PA, USA.
Biomarker and Genomic Sciences Group, National Institute of Standards and Technology, Gaithersburg, MD, USA.
Department of Pediatrics, University of Iowa, Iowa City, IA, USA.
Gladstone Institute of Cardiovascular Disease, Gladstone Institutes, San Francisco, CA, USA.
Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
Office of Research Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, MD, USA.
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA.
Division of Animal Sciences, University of Missouri, Columbia, MO, USA.
Robarts Research Institute and Department of Medical Biophysics, The University of Western Ontario, London, Ontario, Canada.
Department of Pathology, University of California, San Diego, La Jolla, CA, USA.
Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, USA.
Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI, USA.
Morgridge Institute for Research, Madison, WI, USA.
Department of Pediatrics, University of California, Davis, Davis, CA, USA.
Department of Cell Biology and Human Anatomy, University of California, Davis, Davis, CA, USA.
School of Medicine, University of California, Davis, Davis, CA, USA.
California National Primate Research Center, University of California, Davis, Davis, CA, USA.
Department of Nutrition, Case Western Reserve University, Cleveland, OH, USA.
Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Worcester, MA, USA.
Department of Biomedical Engineering, Tufts University, Medford, MA, USA.
Department of Pulmonary Immunology, University of Texas Health Sciences Center at Tyler, Tyler, TX, USA.
Department of Neurosurgery, Yale University, New Haven, CT, USA.

The move from reading to writing the human genome offers new opportunities to improve human health. The United States National Institutes of Health (NIH) Somatic Cell Genome Editing (SCGE) Consortium aims to accelerate the development of safer and more-effective methods to edit the genomes of disease-relevant somatic cells in patients, even in tissues that are difficult to reach. Here we discuss the consortium’s plans to develop and benchmark approaches to induce and measure genome modifications, and to define downstream functional consequences of genome editing within human cells. Central to this effort is a rigorous and innovative approach that requires validation of the technology through third-party testing in small and large animals. New genome editors, delivery technologies and methods for tracking edited cells in vivo, as well as newly developed animal models and human biological systems, will be assembled—along with validated datasets—into an SCGE Toolkit, which will be disseminated widely to the biomedical research community. We visualize this toolkit—and the knowledge generated by its applications—as a means to accelerate the clinical development of new therapies for a wide range of conditions.

中文翻译：

NIH 体细胞基因组编辑计划

从读取人类基因组到编写人类基因组的转变为改善人类健康提供了新的机会。美国国立卫生研究院 (NIH) 体细胞基因组编辑 (SCGE) 联盟旨在加速开发更安全、更有效的方法来编辑患者疾病相关体细胞的基因组，即使是在难以编辑的组织中抵达。在这里，我们讨论了该联盟的计划，以开发和基准化方法来诱导和测量基因组修饰，并定义人类细胞内基因组编辑的下游功能后果。这项工作的核心是一种严格和创新的方法，需要通过第三方对小型和大型动物进行测试来验证该技术。新的基因组编辑器、递送技术和体内追踪编辑细胞的方法，以及新开发的动物模型和人类生物系统，将与经过验证的数据集一起组装成一个 SCGE 工具包，该工具包将广泛传播给生物医学研究界。我们将此工具包及其应用产生的知识可视化为一种手段，以加速针对各种情况的新疗法的临床开发。

更新日期：2021-04-08

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>